Data processing: structural design – modeling – simulation – and em – Simulating nonelectrical device or system – Biological or biochemical
Reexamination Certificate
2005-08-19
2009-02-24
Noakes, Suzanne M. (Department: 1656)
Data processing: structural design, modeling, simulation, and em
Simulating nonelectrical device or system
Biological or biochemical
C702S019000, C702S027000
Reexamination Certificate
active
07496489
ABSTRACT:
This invention relates to progesterone receptor/ligand complex, and related methods and software systems. Methods for designing and/or selecting ligands of the progesterone receptor using the three-dimensional structural coordinates of the progesterone receptor and/or nonsteroidal ligands are disclosed.
REFERENCES:
patent: 5834228 (1998-11-01), Becker et al.
patent: 5856116 (1999-01-01), Wilson et al.
patent: 5939528 (1999-08-01), Clardy et al.
patent: 6562857 (2003-05-01), Collins et al.
patent: WO 99/09148 (1999-02-01), None
patent: WO00/66570 (2000-11-01), None
patent: WO00/66581 (2000-11-01), None
patent: WO2004/000230 (2003-12-01), None
patent: WO2004/000801 (2003-12-01), None
McPherson, A. Current Approaches to Macromolecular Crystallization. European Journal of Biochemistry. 1990. vol. 189, pp. 1-23.
Kundrot, C.E. Which Strategy for a Protein Crystallization Project? Cellular Molecular Life Science. 2004. vol. 61, pp. 525-536.
Cudney R. Protein Crystallization and Dumb Luck. The Rigaku Journal. 1999. vol. 16, No. 1, pp. 1-7.
Ginalski et al., Comparative Modeling for Protein Structure Prediction. Current Opinion in Structural Biololgy, 2006. vol. 16, pp. 172-177.
Zhi et al. Journal of Medicinal Chemistry, 1998, vol. 41, pp. 291-302.
Böhm et al., Journal of Computer-Aided Molecular Design, 1992, vol. 6, pp. 61-78.
Goodsell et al., Journal of Molecular Recognition, 1996, vol. 9, pp. 1-5.
Appendix A -Resuls from DaliLite pairwise comparison of 1ZUC (instant Table 2) with Williams et al. 1A28. No date.
Structural Coordinates of 1A28. No date.
Branden & Tooze, “Introduction to Protein Structure”, Garland Publishing, Inc. New York and London, 1991; p. 249.
International Preliminary Report on Patentability for PCT Application No. PCT/US2005/029711, dated Mar. 1, 2007.
Madauss et al., “Progesterone Receptor Ligand Binding Pocket Flexibility: Crystal Structures of the Norethindrone and Mometasone Furoate Complexes,” J. Med. Chem., vol. 47, No. 13, pp. 3381-3387, Jun. 17, 2004.
Zhang et al., “Novel 6-aryl-1, 4-dihydrobenzo[d][1,3]oxazine-2-thiones as Potent, Selective, and Orally Active Nonsteroidal Progesterone Receptor Agonists,” Bioorganic & Medicinal Chemistry Letters, vol. 13, No. 7, pp. 1313-1316, Apr. 7, 2003.
Klebe, “Recent developments in structure-based drug design,” Journal of Molecular Medicine,Springer Verlag, DE, vol. 78, No. 5, pp. 269-281, Feb. 26, 2000.
Zhang et al., “Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget,” Journal of Biological Chemistry, vol. 280, No. 31, pp. 28468-28475, Aug. 5, 2005.
Fensome et al., “Synthesis and structure-activity relationship of novel 6-aryl-1, 4-dihydrobenzo[d][1,3]oxazine-2-t hiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget,” Journal of Medicinal Chemistry, vol. 48, No. 16, pp. 5092-5095, Aug. 2005.
GenBank Accession No. NM—000926 (Dec. 22, 2003).
Matias et al., “Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen Receptor”J. Biol. Chem. 275:26164-26171 (2000).
Tanenbaum et al., “Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains”Proc. Natl. Acad. Sci. USA95:5998-6003 (1998).
Williams et al., “Atomic structure of progesterone complexed with its receptor”Nature393:392-396 (1998).
Malakian Karl
Olland Andrea M.
Unwalla Rayomand J.
Wilhelm James M.
Lowrie Lando & Anastasi, LLP
Noakes Suzanne M.
Wyeth
LandOfFree
Design of progesterone receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Design of progesterone receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Design of progesterone receptor ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4108152